electroCore to Present at Planet MicroCap Toronto 2026 powered by MicroCapClub
Conference Details:
Dates:
Company Presentation: Wednesday, October 28 at 9:30 am ET
Location: Arcadian Court & Loft,
Webcast: https://event.summitcast.com/view/iiVo9HYfz9sL9CC5m4Dgpv/N22s45azRsLw3U5aeUR5NF
If you would like to book one-on-one investor meetings with electroCore and attend Planet MicroCap Toronto 2026, please register at https://planetmicrocap.com.
About electroCore, Inc.
electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore® non-invasive vagus nerve stimulation (nVNS) and Quell® neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga™ and TAC-STIM™ nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.
For more information, visit www.electrocore.com.
Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com